Iranian
Biomedical Journal
Volume 30, Issue 2 (Supplementary 2026)
IBJ 2026, 30(2): 30-30 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Mollaee Bijarpasi F. Cold Atmospheric Plasma: A Novel Therapeutic Modality for Breast Cancer. IBJ 2026; 30 (2) :30-30
URL: http://ibj.pasteur.ac.ir/article-1-5533-en.html
URL: http://ibj.pasteur.ac.ir/article-1-5533-en.html
Abstract:
Introduction: Breast cancer remains one of the most prevalent and challenging malignancies worldwide, driving the need for innovative and targeted therapeutic strategies. Cold atmospheric plasma (CAP), a partially ionized gas generated at room temperature and atmospheric pressure, has emerged as a promising anticancer agent.
Materials and Methods: CAP did not directly interact with cells through heat, but rather through the delivery of a complex mixture of reactive oxygen and nitrogen species, charged particles, and electric fields. When applied to breast cancer cells in vitro, CAP induced a series of biological effects, including oxidative stress-mediated apoptosis (programmed cell death), cell cycle arrest, and the inhibition of cell migration and invasion, key processes in metastasis.
Results and Discussion: A key advantage of CAP is its selectivity; several studies report that CAP treatment can selectively induce death in malignant cells while causing minimal damage to non-malignant mammary epithelial cells. Furthermore, CAP has shown promise in preclinical models for targeting cancer stem cells, a subpopulation implicated in tumor recurrence and resistance to therapy. In vivo studies using murine models have corroborated these findings, showing significant reductions in tumor growth with direct CAP application.
Conclusion: While the research in this area is still predominantly at the preclinical stage, these compelling results position CAP as a potent, multi-modal, and minimally invasive physical agent for the local and adjuvant treatment of breast cancer.
Materials and Methods: CAP did not directly interact with cells through heat, but rather through the delivery of a complex mixture of reactive oxygen and nitrogen species, charged particles, and electric fields. When applied to breast cancer cells in vitro, CAP induced a series of biological effects, including oxidative stress-mediated apoptosis (programmed cell death), cell cycle arrest, and the inhibition of cell migration and invasion, key processes in metastasis.
Results and Discussion: A key advantage of CAP is its selectivity; several studies report that CAP treatment can selectively induce death in malignant cells while causing minimal damage to non-malignant mammary epithelial cells. Furthermore, CAP has shown promise in preclinical models for targeting cancer stem cells, a subpopulation implicated in tumor recurrence and resistance to therapy. In vivo studies using murine models have corroborated these findings, showing significant reductions in tumor growth with direct CAP application.
Conclusion: While the research in this area is still predominantly at the preclinical stage, these compelling results position CAP as a potent, multi-modal, and minimally invasive physical agent for the local and adjuvant treatment of breast cancer.
 |
Type of Study: Congress |
Subject:
Related Fields
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
IBJ is a member of Committee on Publication Ethics (COPE)
and follows its guidelines |
The articles of this journal are licensed under
a Creative Commons Attribution-NonDerivatives 4.0 International License. .png) |
 IBJ is owned and published by Pasteur Institute of Iran |